SEI Investments’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-17,908
Closed -$2.19M 2541
2020
Q2
$2.19M Sell
17,908
-2,690
-13% -$305K 0.01% 1231
2020
Q1
$1.8M Sell
20,598
-7,490
-27% -$793K 0.01% 1191
2019
Q4
$2.93M Buy
28,088
+6,960
+33% +$780K 0.01% 1157
2019
Q3
$2.43M Buy
21,128
+5,487
+35% +$833K 0.01% 1246
2019
Q2
$2.7M Buy
15,641
+7,789
+99% +$1.35M 0.01% 1195
2019
Q1
$1.32M Buy
7,852
+538
+7% +$80.1K ﹤0.01% 1483
2018
Q4
$1.26M Hold
7,314
﹤0.01% 1454
2018
Q3
$1.26M Buy
7,314
+1,268
+21% +$183K ﹤0.01% 1397
2018
Q2
$844K Buy
6,046
+3,944
+188% +$560K ﹤0.01% 1655
2018
Q1
$236K Buy
2,102
+2,046
+3,654% +$257K ﹤0.01% 1835
2017
Q4
$7K Buy
56
+5
+10% +$587 ﹤0.01% 2895
2017
Q3
$5K Sell
51
-100
-66% -$10.7K ﹤0.01% 2855
2017
Q2
$15K Sell
151
-49
-25% -$5.27K ﹤0.01% 2512
2017
Q1
$24K Buy
+200
New +$24.5K ﹤0.01% 2300

Other funds holding GWPH

SEI Investments's GWPH Position: Q3 2020 in Review

SEI Investments sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 17,908 shares — an estimated $2.19M sold.

SEI Investments first reported a position in GWPH in Q1 2017 and held it in 14 quarters. The position peaked at $2.93M in Q4 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

  • SEI Investments reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • SEI Investments sold 17,908 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $2.19M.
  • SEI Investments first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2017 and held it in 14 quarters.
  • SEI Investments's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.93M in Q4 2019.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on SEI Investments's 13F filing for Q3 2020, filed 6 Nov 2020.